MENLO PARK, Calif. -- Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia's expansion with a 14,700 square-foot pilot plant located next to Antheia's […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Morgan Stanley's Prime Property Fund is marketing 150 California Street, a 249,960-square-foot,...
ByThe RegistryNovember 13, 2026Sanmina has signed a direct lease for roughly 103,000 square feet at...
ByThe RegistryNovember 13, 2026The Santa Clara Valley Transportation Authority has finished the deep launch shaft...
ByThe RegistryNovember 13, 2026Dermody has bought the Tracy 205 Logistics Center, a never-occupied 606,343-square-foot cross-dock...
ByThe RegistryNovember 13, 2026